April Bulletin Vol. 12 - 04
Cholinesterase Inhibitors Exception Status Criteria and Process Revisions; Palliative Home Care Drug Coverage Program Update; Understanding Generic Drugs
Bulletin Attachments:
February Bulletin Vol. 12 - 03
OxyContin®/OxyNEO® Communication; Transition Fees; Changes to the Nova Scotia Formulary on the Pharmacare Website
February Bulletin Vol. 12 - 02
Palliative Home Care Drug Program
Bulletin Attachments:
Palliative Home Care Medication Authorization Form
Direct Deposit Form
January Bulletin Vol. 12 - 01
Calcitonin Intranasal Criteria Code; Transition Fees; Changes to the Formulary on the Pharmacare Website
Bulletin Attachment
Prescriber List - January 2012
Coverage for Antiviral Therapies for Influenza-Like Illness (ILI); Changes to Generic Drug Pricing
Bulletin Attachments:
a) Payment Schedules - 2012
b) Discontinued Products
c) Reimbursement List (Jan. 1, 2012)
d) Reimbursement List (Feb. 1, 2012)
October Bulletin Vol. 11 - 09
Automation of Exception Status Requests; Drug Costs Billed to the Pharmacare Programs; Transition Fees
Bulletin Attachments:
CADTH Optimal Therapy Newsletter
a) Type 2 Diabetes – Second- and Third-Line Therapies
b) When Metformin Alone is Not Enough
September Bulletin Vol. 11 - 08
Insured Professional Services
August Bulletin Vol. 11 - 07
Formulary Updates; Fair Drug Pricing Legislation Clarification; Pharmacare Reimbursement; New Prescribers
Bulletin Attachments:
Request for Credit: Injectable Medication and Ostomy Supplies
July Bulletin Vol. 11 - 06
Update on Exception Status Drug Requests; Changes to Billing for Methadone Oral Liquid; Auditors Corner
Bulletin Attachments:
Pharmacare Tariff Agreement
Confirmation of Agreement
Prescribers List
June Bulletin Vol. 11 - 05
Changes to Generic Drug Pricing
May Bulletin Vol. 11 - 04
Formulary Updates;
Change in Notification: New Interchangeable Products;
Pharmacare Reimbursement;
New Prescribers
April Bulletin Vol. 11 - 03
Pharmacist Prescribing;
New Benefits and Interchangeable Products;
Billing Pharmacare Clients for MAC or Special MAC Drugs
Bulletin Attachment: Pharmacist Exception Status Drug Request Form
March Bulletin Vol. 11 - 02
Fragmin Pre-filled Syringe DIN Change;
New Prescribers;
Product Name and Manufacturer Change;
Change in MAC and Special MAC Pricing
January Bulletin Vol. 11 - 01
Change to Exception Status - Cesamet®;
Update on Proton Pump Inhibitors (PPIs);
Formulary Updates;
Pharmacare Reimbursement
December Bulletin Vol. 10 - 14 Formulary Updates; Atorvastatin Adjustment
November Bulletin Vol. 10 - 13
New Interchangeable Products; Change in MAC Pricing
November Bulletin Vol. 10 - 12
Correction to MAC Pricing-Atorvastatin
November Bulletin Vol. 10 - 11
Pharmacare Reimbursement: Change in MAC Pricing - Atorvastatin; Formulary Updates
(See also corrections provided in Vol. 10 - 12)
September Bulletin Vol. 10 - 10
Formulary Updates; Pharmacare Reimbursement;
Auditors' Corner: Insured Compounded Products
July Bulletin Vol. 10 - 09
New Benefits; New Interchangeable Products; Reimbursement for Unreturnable Injectable Medication
July Bulletin Vol. 10 - 08
New Pharmacare Tariff Agreement; Reimbursement List
June Bulletin Vol. 10 - 07
Formulary Updates; Pharmacare Reimbursement; Auditors' Reminder: Continuing Care Prescriptions
May Bulletin Vol. 10 - 06
Reminder: Beneficiaries with Other Insurance; Formulary Updates; New Generic Products
April Bulletin Vol. 10 - 05
Notification of Change: Nova Scotia Diabetes Assistance Program
Antiviral Therapies for Influenza-Like Illness; Formulary Updates
March Bulletin Vol. 10 - 04
Update II - Blood Glucose Monitoring Strips
March Bulletin Vol. 10 - 03
Update - Blood Glucose Monitoring Strips
February Bulletin Vol. 10 - 02
Program Information; Formulary Updates
January Bulletin Vol. 10 - 01
New Products; New Interchangeable Products
April Bulletin Vol. 12 - 03
Cholinesterase Inhibitors Exception Status Criteria and Process Revisions; Understanding Generic Drugs
March Bulletin Vol. 12 - 02
OxyContin/OxyNEO Communication; Palliative Home Care Drug Coverage Program; Changes to the Nova Scotia Formulary on the Pharmacare Website
Bulletin Attachments:
February Bulletin Vol. 12 - 01
Calcitonin Intranasal Criteria Code; Non-Insured Products; Changes to the Formulary on the Pharmacare Website
December Bulletin Vol. 11 - 07
Coverage for Antiviral Therapies for Influenza-Like Illness (ILI); Formulary Updates
October Bulletin Vol. 11 - 06
Automation of Exception Status Requests; New Exception Status Benefit ; Non-Insured Products
Bulletin Attachments:
CADTH Optimal Therapy Newsletter
a) Type 2 Diabetes – Second- and Third-Line Therapies
b) When Metformin Alone is Not Enough
August Bulletin Vol. 11 - 05
New Exception Status Benefit ; Non-Insured Products
July Bulletin Vol. 11 - 04
Update on Exception Status Drug Requests; Formulary Updates; Reminder: Include CPSNS Number When Submitting Requests for Coverage of Exception Status Drugs
May Bulletin Vol. 11 - 03
New Products;
New Exception Status Benefit;
Non-Insured Products
April Bulletin Vol. 11 - 02
Formulary Updates; Criteria Update - Humira; New Exception Status Benefits; Non-Insured Products
February Bulletin Vol. 11 - 01
Change to Exception Status - Cesamet®; Update on Proton Pump Inhibitors (PPIs); Formulary Updates
Crown copyright 2011, Province of Nova Scotia, all rights reserved.
Page last updated 2012-04-17.